Rotavirus in Europe – burden, management and prevention
|
|
Tuesday, May 01, 2007
|
ESPID Rota Symposium:
Rotavirus In Europe- Burden, Management And Prevention
|
|
| Chairpersons: | Ron Dagan, Israel | | | Timo Vesikari, Finland |
|
|
|
Session I: Disease and Immunity
Chairperson: R. Dagan, Israel
|
|
18:00 |
Introduction
R. DAGAN 11 Soroka Medical Center, Beer Sheva, Israel;
|
|
18:05 |
Burden of rotavirus disease in Europe
C. GIAQUINTO 11 Department Of Pediatrics, University Of Padova, Padova, Italy;
|
|
18:25 |
Management of acute gastroenteritis in modern era
A. GUARINO 1, F. Albano 1, A. Ashkenazi 2, D. Gendrel 3, H. Hoekstra 4, A. Lo Vecchio 1, R. Shamir 5, H. Szajewska 6Napoli, Italy;
Ramat -Gan, Israel;
Paris, France;
s-Hertogenbosch, The Netherlands;
Haifa, Israel;
Worsow, Poland;
|
|
18:45 |
Immune protection against rotavirus
T. VESIKARI 11 Vaccine Research Center, Medical School, University Of Tampere, Tampere, Finland;
|
|
19:05 |
Questions and answers
|
|
19:20 |
Coffee Break
|
|
19:40 |
Session II: Prevention of Rotavirus Disease
Chairperson: T. Vesikari, Finland
|
|
19:40 |
RotaTeq® – Pentavalent Rotavirus Vaccine
N. KITCHIN 11 Medical Director, Sanofi Pasteur MSD UK;
|
|
20:00 |
Rotarix™ – state of the art
B. DE VOS 11 GlaxoSmithKline Biologicals, Rixensart, Belgium;
|
|
20:20 |
Evidence-based recommendations for the use of rotavirus vaccines in Europe
P. VAN DAMME 11 On Behalf Of ESPID-ESPGHAN Rotavirus Expert Working Group Centre For The Evaluation Of Vaccination, Faculty Of Medicine, University Of Antwerp, Antwerp, Belgium;
|
|
20:40 |
Round Table: Implementation of rotavirus vaccines in Europe
Moderator: P. Van Damme, Belgium
C. Giaquinto, Italy, B. De Vos, GSK, G. Cordeiro Ferreira, Portugal, P. Lopalco, ECDC, I. Mutz, Austria, M. Goveia, USA
|
|
20:55 |
Conclusions
|
|
|
|
